AYTUW

Aytu BioScience, Inc.

 
Warrants SEC Reporting - Current
OTCQX U.S.
Verified Company Profile 5/31/2017
Contact Info
  • 373 Inverness Parkway
  • Suite 206
  • Englewood, CO 80112

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0001385818
Fiscal Year End 6/30
OTC Marketplace OTCQX U.S.
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2015
Employees 53 a/o May 30, 2017
Company Officers/Contacts
Joshua Robert Disbrow CEO
Jarrett Disbrow COO
Gregory A. Gould CFO
Company Directors
Gary Cantrell Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Carl C Dockery Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
John Donofrio, Jr. Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Michael Emil Macaluso
Service Providers
Accounting/Auditing Firm

Not Available
Securities Counsel

Not Available
Investor Relations Firm

Not Available
Company History
  • Sponsored for OTCQX by Wyrick Robbins Yates & Ponton LLP on 12/14/2015.
  • Formerly=Rosewind Corp. until 6-2015
AYTUW Security Details Other Company Securities
Share Structure
Market Value1 $42,188 a/o Jun 23, 2017
Authorized Shares 21,562,500 a/o Jun 14, 2017
Outstanding Shares 544,012 a/o Jun 14, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders
Shareholders of Record Not Available
Short Selling Data
Short Interest 0 (-100%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security